Clinical Drug Experience Knowledgebase

Acute-On-Chronic Liver Failure (Phase 2)

Alveolar Bone Loss (Phase 2)

Arterial Occlusive Diseases (Phase 2)

Carcinoma, Pancreatic Ductal (Phase 2)

Communicable Diseases (Phase 3)

Coronavirus Infections (Phase 3)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Foot (Phase 2)

Disease (Phase 2)

End Stage Liver Disease (Phase 2)

Epidermolysis Bullosa (Phase 2)

Epidermolysis Bullosa Dystrophica (Phase 2)

Epilepsies, Partial (Phase 3)

Epilepsy (Phase 3)

Fabry Disease (Phase 1)

Familial Primary Pulmonary Hypertension (Phase 2)

Foot Ulcer (Phase 2)

Hepatic Insufficiency (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hyperhidrosis (Phase 1)

Hypertension (Phase 2)

Infections (Phase 4)

Kidney Diseases (Phase 2)

Liver Failure (Phase 2)

Malaria (Phase 1)

Malaria, Falciparum (Phase 1)

Migraine Disorders (Phase 2)

Neoplasms (Phase 1)

Neuralgia (Phase 2)

Parasitemia (Phase 1)

Parasitic Diseases (Phase 1)

Parkinson Disease (Phase 3)

Peripheral Arterial Disease (Phase 2)

Protozoan Infections (Phase 1)

Renal Insufficiency, Chronic (Phase 2)

Respiratory Tract Infections (Phase 3)

Skin Ulcer (Phase 2)

Syndrome (Phase 2)

Tic Disorders (Phase 2)

Tics (Phase 2)

Tourette Syndrome (Phase 2)

Ulcer (Phase 2)

Varicose Ulcer (Phase 2)

Virus Diseases (Phase 2)